Partners

AP-HP

Assistance Publique - Hôpitaux de Paris (AP-HP) is a public health federation that gathers together 37 hospitals for the Paris metropolitan area. Its activities are medical care (750 medical units / 52 medical and biological specialties), education (37 formation centers), and research performed either independently (AP HP labs and pharmaceutical departments), in partnership with hosted research units (112 INSERM and 30 CNRS units), or in partnership with external entities (public and private).

AP-HP, via its pharmaceutical department "AGEPS", has developed and patented new pharmaceutical formulations of 3,4-DAP for indications in different kinds of diseases, for example the treatment of  Lambert-Eaton myasthenic syndrome or multiple sclerosis.

For more information see www.aphp.fr